Sponsored talk at Discovery on Target 2018

Dr. Michael Hennig, CEO of leadXpro, will talk about the company’s experience with the Creoptix WAVE system when measuring ligand binding and kinetics to support drug design on September 27th at 3:55 pm.

 

Last modified onThursday, 06 September 2018 11:05